GLP-1 R 40 mg
GLP-1 R 40 mg - Image 2
GLP-1 R 40 mg - Image 3
GLP-1 R 40 mg - Image 4
GLP-1 R 40 mg - Image 5
GLP-1 R 40 mg - Image 6

GLP-1 R 40 mg

$160.00

Retatrutide 40 mg — triple GLP-1/GIP/glucagon receptor agonist studied for metabolic function, appetite regulation, energy balance, and body-weight management. For research use only.

Category:

Description

Retatrutide 40 mg is a research peptide being studied as a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors. Current research is investigating its potential effects on metabolic function, energy balance, appetite regulation, and body-weight management.

Supplied in lyophilized form for research purposes.
For research use only. Not FDA-approved for human use.

Related products